Phân tích mức độ tiêu thụ kháng sinh fosfomycin tại Bệnh viện Trung ương Quân đội 108 từ năm 2020 đến năm 2022

Abstract

Objective: Study on consumption of fosfomycin antibiotic in 108 Military Center Hospital from 2020 to 2022; Orientation for the fosfomycin management program for the hospital. Subject and method: The number of fosfomycin antibiotic was used in clinical departments that belong to  the 108 Military Center Hospital from 2020 to 2022, statistic on number of patient-days of internal patients. Result: The consumption of fosfomycin antibiotic from 2020 to 2022 was increased and the number DDD/100 patient-days in 2022 increased 1.7 times compared to 2020. Department of airborne infectious diseases and intensive care, ICU and Endocrinology department were the largest consuming units of fosfomycin with DDD/100 patient-days was 3.06, 2.99, 2.81 respectively. The trend of increasing consumption of fosfomycin in the hospital and ICUs, Endocrinology department were not been identified with Mann-Kendall test for hospital S= 129 p=0.08 (>0.05) and for ICU and Endocrinology p>0.05 too. Conclusion: The study has shown an overall image of the consumption of the antibiotic fosfomycin at 108 Military Central Hospital in the period 2020 - 2022, with the consumption in 2022 of the number of DDD doses/100 days of treatment being 1.7 times higher than in 2020. The airborne infectious diseases and Intensive care, ICU and Endocrinology were the units with the largest consumption of fosfomycin in the Hospital, in which the airborne infectious diseases and intensive care the total number of DDD/100 patient-days of treatment in the 3 years 2020 - 2022 was 3.06 , the ICU was 2.99, and the Endocrinology Department is 2.81.